Rie Tanaka

Rie Tanaka is an accomplished finance professional with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as Head of Accounting and Finance at Krystal Biotech, Inc. since April 2025, Rie has held prominent positions at several leading firms including Moderna, where responsibilities included overseeing finance in Japan, and Alnylam Pharmaceuticals as Finance Director for Asia. Previous roles also encompass Executive Director of Finance at Bioverativ, Finance Director at Biogen, Finance Director for APAC Supply Chain at The Estée Lauder Companies, and Finance Director at Zoetis and Pfizer. Rie began a career at Pfizer in 1998, advancing through various finance management roles, and holds a degree from Doshisha University.